Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies.
Berkowitz L, Razquin C, Salazar C, Biancardi F, Estruch R, Ros E, Fitó M, Corella D, Coe CL, Ryff CD, Ruiz-Canela M, Salas-Salvado J, Wang D, Hu FB, Deik A, Martínez-Gonzalez MA, Rigotti A.
Berkowitz L, et al. Among authors: biancardi f.
Cardiovasc Diabetol. 2024 Dec 18;23(1):446. doi: 10.1186/s12933-024-02505-7.
Cardiovasc Diabetol. 2024.
PMID: 39695759
Free PMC article.